Tag Archives: Advertising compliance and enforcement

The TGA and COVID-19: Starting to use its compliance teeth!

Significant changes were made to the advertising framework of therapeutic goods during 2018-19. These included the TGA taking over the advertising complaint system, an updated, legally enforceable, advertising Code and stronger investigative and compliance powers. Yet the TGA initially appeared … Continue reading

Posted in Advertising | Tagged , | Leave a comment

TGA new complaint system: compliance notices ineffective

Two outcomes (of 16) TGA complaints have now been received. AC-E7JS15BB/2018, submitted 3/8/18,  Brand Developers Australia Pty Ltd – Pain Erazor https://www.youtube.com/watch?v=ye6s7qB-4Gc&feature=youtu.be “Pain Erazor” (ATG no: 276939) won a 2017 Choice “Shonky” award, was the subject of a scathing N.Z. Consumer review, … Continue reading

Posted in Medical Devices, Pharmaceutical Promotion | Tagged , , , , , | Leave a comment

Seminar: The Advertising of Therapeutic Goods and Services (and its regulation), Sept 8, 2017

In March 2016, a seminar on this topic attracted over 100 people to the Sydney University Health Law Centre. One outcome was a decision to hold a follow-up seminar in Melbourne in Sept-Oct 2017. The 2017 seminar is being organised … Continue reading

Posted in Complementary medicine, Education, Medicine policy, Pharmaceutical Promotion, Weight loss | Tagged , , , , , , , , , , | 1 Comment